APA (7th ed.) Citation

Y, C., JR, P., RB, K., J, J., M, W., W, L., . . . B, P. (2019). Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Brain : a journal of neurology, 142(2), 344. https://doi.org/10.1093/brain/awy322

Chicago Style (17th ed.) Citation

Y, Chen, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, and Popko B. "Sephin1, Which Prolongs the Integrated Stress Response, Is a Promising Therapeutic for Multiple Sclerosis." Brain : A Journal of Neurology 142, no. 2 (2019): 344. https://doi.org/10.1093/brain/awy322.

MLA (9th ed.) Citation

Y, Chen, et al. "Sephin1, Which Prolongs the Integrated Stress Response, Is a Promising Therapeutic for Multiple Sclerosis." Brain : A Journal of Neurology, vol. 142, no. 2, 2019, p. 344, https://doi.org/10.1093/brain/awy322.